|
C18ORF54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99540000078713E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.025030E-04 |
| Normal-vs-Stage2 |
1.388610E-01 |
| Normal-vs-Stage3 |
7.464500E-03 |
| Normal-vs-Stage4 |
7.817600E-02 |
| Stage1-vs-Stage2 |
5.414600E-01 |
| Stage1-vs-Stage3 |
1.599630E-01 |
| Stage1-vs-Stage4 |
6.647400E-01 |
| Stage2-vs-Stage3 |
7.692400E-01 |
| Stage2-vs-Stage4 |
7.821200E-01 |
| Stage3-vs-Stage4 |
5.570200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.11800000052776E-07 |
| Normal-vs-AfricanAmerican |
9.823100E-03 |
| Normal-vs-Asian |
1.132760E-01 |
| Caucasian-vs-AfricanAmerican |
7.953600E-01 |
| Caucasian-vs-Asian |
2.372000E-01 |
| AfricanAmerican-vs-Asian |
4.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99314000000061E-05 |
| Normal-vs-Female |
1.79181999999667E-05 |
| Male-vs-Female |
6.824500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.902300E-03 |
| Normal-vs-Extreme_Weight |
4.840900E-03 |
| Normal-vs-Obese |
3.960400E-04 |
| Normal-vs-Extreme_Obese |
8.951800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.100800E-01 |
| Normal_Weight-vs-Obese |
4.228200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.558240E-01 |
| Extreme_Weight-vs-Obese |
9.988500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.822400E-01 |
| Obese-vs-Extreme_Obese |
1.468480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.484100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.60439999963691E-07 |
| Normal-vs-Age(61-80Yrs) |
2.464700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.635800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.677600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.296130E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.107700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.172400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.303800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.780000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.74359999455854E-08 |
| Normal-VS-Type2 PRCC |
4.684600E-01 |
| Normal-VS-KIRP CIMP |
1.781850E-03 |
| Normal-VS-Unclassified PRCC |
4.295800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.60020000478301E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.881900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.362600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.584260E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.439300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.598900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.236200E-02 |
| Normal-vs-N1 |
3.442200E-03 |
| Normal-vs-N2 |
3.049600E-01 |
| N0-vs-N1 |
1.463250E-01 |
| N0-vs-N2 |
8.586000E-01 |
| N1-vs-N2 |
6.028600E-01 |
|
|
